Trial Profile
A randomized, placebo-controlled study evaluated the effects of rosuvastatin in patients undergoing coronary bypass surgery due to coronary artery disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 15 Oct 2016 New trial record